Summary:
ADAPTIVE IMMUNESENSE IBD STUDY!
IBD causes chronic inflammation of the GI tract. The two most common forms of IBD are Crohn’s disease and ulcerative colitis. If you have gastrointestinal (GI) symptoms, find out if you qualify for a clinical study for which you will be compensated.
Participants will be required to have their blood drawn at initial visit, at 6 weeks, 6 months, and 1 year.
To qualify, you must:
- Be age 7+
- Recently diagnosed with IBD and have not yet started treatment
- GI symptoms and have a planned endoscopy, but have not yet received a diagnosis
- Recently Been Diagnosed with at least one of the following:
- Celiac Disease
- Infection diarrhea
- Irritable Bowel Syndrome (IBS)
Qualified Participants May Receive:
Eligible patients will be compensated $100 for each blood draw